loading page

Analysis of COVID 19 Infection in Chronic Kidney Disease and Kidney Transplant Patients in Pandemic Hospital: What Has the Last Year Taught Us?
  • +1
  • nurettin ay,
  • Ramazan Danis,
  • Jehat Kılıc,
  • Derya Deniz Altıntaş
nurettin ay
Diyarbakir Gazi Yasargil Training and Research Hospital

Corresponding Author:nurettinay77@hotmail.com

Author Profile
Ramazan Danis
Author Profile
Jehat Kılıc
Diyarbakir Gazi Yasargil Training and Research Hospital
Author Profile
Derya Deniz Altıntaş
Diyarbakir Gazi Yasargil Egitim ve Arastirma Hastanesi
Author Profile


Objective: This study aims to investigate the mortality factors in hemodialysis patients and kidney transplant patients with COVID-19 patients. Method: The demographic, clinic, laboratory, and radiologic signs of the kidney transplant and hemodialysis patients diagnosed with COVID-19 between 11 March 2020-11 March 2021 were evaluated. Results: To this study, 72 hemodialysis (median age, 57.5 Q1-Q3:43-65; female:36/50%) and 58 kidney transplant (median age, 44.5 Q1-Q3:28.75-55.25; female:21/36.2%) were included. Fifteen HD patients (20.8%) died. To identify the independent predictors of in-hospital mortality, multivariable logistic regression analyses were performed using the variables in the univariate analyses including age, female gender, diabetes mellitus, ferritin, d-dimer, albumin, CRP, procalcitonin, dyspnea. Age (OR:1.12, 95% [CI]: 1.03-1.21, p=0.004), and dyspnea (OR: 9,7 95% CI 1.80-52.2, p=0.008) were found to be associated with in-hospital mortality. Nine (15.5%) of transplant patients died. The median time from the beginning of symptoms to the time of admission was 3 days (2-5). And this rate was 2 (2-3) and 5 (4-5.75) days, respectively, for patients followed up in our center and the external centers (p<0.001). Although an increase in CRP, ferritin, D-dimer levels, dyspnea, and bilateral involvement in CT images was statistically significant in the univariate analysis, no single factor was found to be related to mortality in multivariate analysis. Conclusion: Both HD and renal transplant patients should be followed closely. Early admission of HD and RT patients might be life-saving when suspected. Early inclusion of these patients into the vaccination program might reduce mortality. However, large-scale prospective randomized studies are needed.